Atanassov Christo, Pezennec Leon, d'Alayer Jacques, Grollier Ghislaine, Picard Bertrand, Fauchère Jean-Louis
Department of Microbiology A, IFR 59, University Hospital Center, 86021 Poitiers, France.
J Clin Microbiol. 2002 Feb;40(2):547-52. doi: 10.1128/JCM.40.2.547-552.2002.
Recently, we reported that the patterns of antibodies to Helicobacter pylori protein antigens in serum may be useful for screening patients at high risk for ulcers (P. Aucher et al., J. Clin. Microbiol. 36:931-936, 1998). Here we report the identification, by a combination of electrophoretic, immunochemical, and protein sequencing methods, of five antigens that correspond to this antibody pattern: groEL, catalase A, flagellin A, beta-ketoacyl-acyl carrier protein synthase I (beta-ketoacyl-ACP S), and peptidyl prolyl cis-trans isomerase (PPiase). Beta-Ketoacyl-ACP S and PPiase are reported for the first time as antigens of diagnostic interest in infections by H. pylori. The antigenicity of the five antigens, together with those of CagA and VacA, was tested in an immunoblot assay with water-soluble protein extracts from two H. pylori pathogenic strains (HP 141 and ATCC 43579) and panels of sera from H. pylori-positive patients with gastroduodenal ulcers (GDU), nonulcer dyspepsia (NUD), as well as sera from H. pylori-negative healthy volunteers. For catalase A, groEL, and flagellin A antigens, no overall statistically important values were found making it possible to discriminate between patients with GDU and NUD. For both H. pylori strains, the mean performance indices (MPI) presenting percentages of correctly classified patients with GDU and NUD showed that the most significant antibody patterns were as follows: anti-VacA + anti-beta-ketoacyl-ACP S (MPI = 76.1), anti-VacA + anti-PPiase (MPI = 71.8), and anti-CagA + anti-VacA + anti-beta-ketoacyl-ACP S (MPI = 70.5). Antibody patterns detected with these antigen profiles may therefore be useful in developing a diagnostic test designed to predict the clinical severity of the H. pylori infection within the adult population of France.
最近,我们报道血清中幽门螺杆菌蛋白抗原的抗体模式可能有助于筛查溃疡高危患者(P. Aucher等人,《临床微生物学杂志》36:931 - 936,1998年)。在此,我们通过电泳、免疫化学和蛋白质测序方法相结合,报告了与该抗体模式相对应的五种抗原:热休克蛋白60(groEL)、过氧化氢酶A、鞭毛蛋白A、β - 酮脂酰 - 酰基载体蛋白合成酶I(β - 酮脂酰 - ACP S)和肽基脯氨酰顺反异构酶(PPiase)。β - 酮脂酰 - ACP S和PPiase首次作为幽门螺杆菌感染中具有诊断意义的抗原被报道。用来自两种幽门螺杆菌致病菌株(HP 141和ATCC 43579)的水溶性蛋白提取物以及来自幽门螺杆菌阳性的胃十二指肠溃疡(GDU)患者、非溃疡性消化不良(NUD)患者的血清样本,还有幽门螺杆菌阴性的健康志愿者的血清,通过免疫印迹分析检测了这五种抗原以及细胞毒素相关蛋白A(CagA)和空泡毒素A(VacA)的抗原性。对于过氧化氢酶A、groEL和鞭毛蛋白A抗原,未发现能区分GDU患者和NUD患者的总体统计学显著值。对于两种幽门螺杆菌菌株,呈现正确分类GDU患者和NUD患者百分比的平均性能指数(MPI)表明,最显著的抗体模式如下:抗VacA + 抗β - 酮脂酰 - ACP S(MPI = 76.1)、抗VacA + 抗PPiase(MPI = 71.8)以及抗CagA + 抗VacA + 抗β - 酮脂酰 - ACP S(MPI = 70.5)。因此,用这些抗原谱检测到的抗体模式可能有助于开发一种诊断测试,用于预测法国成年人群中幽门螺杆菌感染的临床严重程度。